Compare Enveric Biosciences Inc (ENVB) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs HCA Health Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while HCA Health Inc trades at $411.49 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 14367.7× Enveric Biosciences Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HCA | |
|---|---|---|
Market Cap | $6.20M | $89.08B |
Sector | Health | Health |
52-Week High | $17.40 | $545.13 |
52-Week Low | $1.27 | $361.32 |
Enterprise Value | $1.30M | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
